Cargando…
Genetic Characterization of the Factor VIII Gene in a Cohort of Colombian Patients with Severe Hemophilia A with Inhibitors
Hemophilia A is an X-linked bleeding disorder caused by mutations in the FVIII gene. Genetic factors have been shown to be a risk factor for the development of inhibitors. We aimed to identify the specific variations of the FVIII gene of patients with hemophilia A with inhibitors and their associati...
Autores principales: | Doncel, Samuel Sarmiento, Mosquera, Gina Alejandra Diaz, Pelaez, Ronald Guillermo, Cortes, Javier Mauricio, Rico, Carol Agudelo, Cadavid, Francisco Javier Meza, Plazas, Nelson Ramirez, Amar, Ivan Alfredo Perdomo, Siado, Jorge Enrique Peña, Rey, Fabian Andres Parrado, Montaño, Cesar Alberto, Villadiego, Alexys Maza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149853/ https://www.ncbi.nlm.nih.gov/pubmed/35645303 http://dx.doi.org/10.3390/hematolrep14020022 |
Ejemplares similares
-
Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
por: Sarmiento Doncel, Samuel, et al.
Publicado: (2021) -
Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors
por: Sarmiento Doncel, Samuel, et al.
Publicado: (2023) -
Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
por: Karakuş, Volkan, et al.
Publicado: (2012) -
Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor
por: Abt, Nicholas B., et al.
Publicado: (2014) -
The factor VIII treatment history of non‐severe hemophilia A
por: Abdi, Amal, et al.
Publicado: (2020)